tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
XERS is currently covered by 3 analysts with an average price target of $8. This is a potential upside of $3.89 (94.65%) from yesterday's end of day stock price of $4.11.
Xeris Pharmaceuticals's activity chart (see below) currently has 22 price targets and 27 ratings on display. The stock rating distribution of XERS is 84.62% BUY and 15.38% HOLD.
Analysts average stock forecasts to be materialized ratio is 22.69% with an average time for these price targets to be met of 194.83 days.
Highest price target for XERS is $8, Lowest price target is $4, average price target is $5.5.
Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 07-Mar-2025. First documented stock forecast 16-Jul-2018.
Currently out of the existing stock ratings of XERS, 11 are a BUY (84.62%), 2 are a HOLD (15.38%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
$3.89 (94.65%)
$6.6
1 months 12 days ago
(07-Mar-2025)
3/12 (25%)
$3.76 (88.68%)
961
Hold
$4
$-0.11 (-2.68%)
$3
1 months 12 days ago
(07-Mar-2025)
4/4 (100%)
$-0.24 (-5.66%)
170
Buy
$4.5
$2.06 (84.43%)
$6.5
1 years 7 months 23 days ago
(28-Aug-2023)
0/2 (0%)
$2.23 (98.24%)
Buy
$6
$2.25 (60.00%)
3 years 1 months 3 days ago
(16-Mar-2022)
0/1 (0%)
$3.21 (115.05%)
Buy
$8
$3.89 (94.65%)
$9
3 years 8 months 13 days ago
(06-Aug-2021)
1/9 (11.11%)
$5.69 (246.32%)
38
What is XERS (Xeris Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on XERS (Xeris Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on XERS (Xeris Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on XERS (Xeris Pharmaceuticals)?
Which analyst is the currently most bullish on XERS (Xeris Pharmaceuticals)?
Which analyst is the currently most reserved on XERS (Xeris Pharmaceuticals)?
